These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 9773747)

  • 1. Methionine synthase D919G mutation in type 2 diabetes and its relation to vascular events.
    Cai H; Wang X; Colagiuri S; Wilcken DE
    Diabetes Care; 1998 Oct; 21(10):1774-5. PubMed ID: 9773747
    [No Abstract]   [Full Text] [Related]  

  • 2. The frequency of a common mutation of the methionine synthase gene in the Australian population and its relation to smoking and coronary artery disease.
    Wang XL; Cai H; Cranney G; Wilcken DE
    J Cardiovasc Risk; 1998; 5(5-6):289-95. PubMed ID: 9919998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida.
    Wilson A; Platt R; Wu Q; Leclerc D; Christensen B; Yang H; Gravel RA; Rozen R
    Mol Genet Metab; 1999 Aug; 67(4):317-23. PubMed ID: 10444342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Methionine synthase and neural tube defects].
    Zhao T; Zhu H; Li Y
    Wei Sheng Yan Jiu; 2000 Nov; 29(6):397-400. PubMed ID: 12520968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations.
    Harmon DL; Shields DC; Woodside JV; McMaster D; Yarnell JW; Young IS; Peng K; Shane B; Evans AE; Whitehead AS
    Genet Epidemiol; 1999 Nov; 17(4):298-309. PubMed ID: 10520212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased cardiovascular morbidity and mortality in type 2 diabetes is associated with the glutathione S transferase theta-null genotype: a Go-DARTS study.
    Doney AS; Lee S; Leese GP; Morris AD; Palmer CN
    Circulation; 2005 Jun; 111(22):2927-34. PubMed ID: 15927971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The (Ala-Val) mutation of methylenetetrahydrofolate reductase as a genetic risk factor for vascular disease in non-insulin-dependent diabetic patients.
    Brulhart MC; Dussoix P; Ruiz J; Passa P; Froguel P; James RW
    Am J Hum Genet; 1997 Jan; 60(1):228-9. PubMed ID: 8981966
    [No Abstract]   [Full Text] [Related]  

  • 8. The methionine synthase polymorphism c.2756Aright curved arrow G (D919G) is relevant for disease-free longevity.
    Linnebank M; Fliessbach K; Kolsch H; Rietschel M; Wullner U
    Int J Mol Med; 2005 Oct; 16(4):759-61. PubMed ID: 16142417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pro12Ala missense mutation of the peroxisome proliferator activated receptor gamma and diabetes mellitus.
    Ringel J; Engeli S; Distler A; Sharma AM
    Biochem Biophys Res Commun; 1999 Jan; 254(2):450-3. PubMed ID: 9918859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The MTHFR CT polymorphism confers a high risk for stroke in both homozygous and heterozygous T allele carriers with Type 2 diabetes.
    Hermans MP; Gala JL; Buysschaert M
    Diabet Med; 2006 May; 23(5):529-36. PubMed ID: 16681562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphism of the methionine synthase gene : association with homocysteine metabolism and late-onset vascular diseases in the Japanese population.
    Morita H; Kurihara H; Sugiyama T; Hamada C; Kurihara Y; Shindo T; Oh-hashi Y; Yazaki Y
    Arterioscler Thromb Vasc Biol; 1999 Feb; 19(2):298-302. PubMed ID: 9974410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Betaine-homocysteine methyltransferase (BHMT): genomic sequencing and relevance to hyperhomocysteinemia and vascular disease in humans.
    Heil SG; Lievers KJ; Boers GH; Verhoef P; den Heijer M; Trijbels FJ; Blom HJ
    Mol Genet Metab; 2000 Nov; 71(3):511-9. PubMed ID: 11073719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The relationship of methylenetetrahydrofolate reductase gene polymorphism and plasma homocysteine levels in type 2 diabetes mellitus patients with diabetic retinopathy].
    Sun J; Xu Y; Zhu Y; Lu H; Deng H; Fan Y; Sun S; Zhang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):131-4. PubMed ID: 12673582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A common Glu298-->Asp (894G-->T) mutation at exon 7 of the endothelial nitric oxide synthase gene and vascular complications in type 2 diabetes.
    Cai H; Wang X; Colagiuri S; Wilcken DE
    Diabetes Care; 1998 Dec; 21(12):2195-6. PubMed ID: 9839121
    [No Abstract]   [Full Text] [Related]  

  • 15. The C677T methylenetetrahydrofolate reductase gene mutation and nephropathy in type 2 diabetes mellitus.
    Ksiazek P; Bednarek-Skublewska A; Buraczyńska M
    Med Sci Monit; 2004 Feb; 10(2):BR47-51. PubMed ID: 14737040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homocysteine, folate, methylene tetrahydrofolate reductase genotype and vascular morbidity in diabetic subjects.
    Kaye JM; Stanton KG; McCann VJ; Vasikaran SD; Burke V; Taylor RR; van Bockxmeer FM
    Clin Sci (Lond); 2002 Jun; 102(6):631-7. PubMed ID: 12049616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between I/D polymorphism of angiotensin I converting enzyme gene and microvascular complications in type 2 diabetic patients].
    Moleda P; Majkowska L; Safranow K; Adler G; Goracy I
    Przegl Lek; 2007; 64(3):134-9. PubMed ID: 17941464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The methionine synthase polymorphism c.2756A>G (D919G) influences diastolic blood pressure.
    Moskau S; Farmand S; Semmler A; Wüllner U; Pohl C; Klockgether T; Linnebank M
    J Hum Hypertens; 2007 May; 21(5):418-20. PubMed ID: 17287836
    [No Abstract]   [Full Text] [Related]  

  • 19. NOS3 polymorphisms are associated with arterial stiffness in children with type 1 diabetes.
    Zineh I; Beitelshees AL; Haller MJ
    Diabetes Care; 2007 Mar; 30(3):689-93. PubMed ID: 17327342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relation of polymorphism of genes controlling endothelial function and blood pressure and the occurrence of vascular complications in type 2 diabetes].
    Mosorjáková D; Kyslanová L; Kozárová M; Tkác I
    Vnitr Lek; 2002 Aug; 48(8):749-54. PubMed ID: 12425206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.